|
Aug 10
|
Do Insulet's (NASDAQ:PODD) Earnings Warrant Your Attention?
|
|
Aug 9
|
Is Insulet (PODD) Significantly Undervalued? A Comprehensive Valuation Analysis
|
|
Aug 9
|
Insulet (PODD) Q2 Earnings Beat, Sales Growth View Raised
|
|
Aug 8
|
Here's What Key Metrics Tell Us About Insulet (PODD) Q2 Earnings
|
|
Aug 8
|
Insulet (PODD) Tops Q2 Earnings and Revenue Estimates
|
|
Aug 8
|
Insulet Reports Second Quarter 2023 Revenue Increase of 32% Year-Over-Year (32% Constant Currency1)
|
|
Aug 8
|
Is Insulet Corp (PODD) Significantly Undervalued? A Comprehensive Analysis
|
|
Aug 8
|
Here's Why You Should Retain Insulet (PODD) Stock for Now
|
|
May 2
|
Insulet Publishes 2022 Sustainability Report Focused on Innovating for the Future and Preserving the Environment
|
|
May 1
|
BellRing Brands (BRBR) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
|
|
Apr 27
|
Insulet (PODD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
Apr 27
|
The Zacks Analyst Blog Highlights BioRad Laboratories, Henry Schein, Insulet, Abbott and LabCorp
|